NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia...

38
NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels

Transcript of NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia...

Page 1: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

NANOFORCEAssociation of the Chemical and Pharmaceutical Industry of the

Slovak Republic

Silvia Surova25.9.2012

Social Dialogue Brussels

Page 2: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 3: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

NANOFORCE project presentation

"Nanotechnology is an area which has highly promising prospects for turning fundamental research into successful

innovations.

Not only to boost the competitiveness of our industry but also to create new products that will make positive

changes in the lives of our citizens, be it in medicine, environment, electronics or any other field."

Janez Potočnik European Commissioner for Science & Research

Page 4: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Partnership

LP SC - Sviluppo Chimica spa (IT)

PP2 Veneto Nanotech S.C.p.A. (IT)

PP3 Association of Chemical Industry of the Czech Republic – SCHP (CZ)

PP4 Chemistry Cluster Bavaria (DE)

PP5 Polish Chamber Of Chemical Industry - PIPC (PL)

PP6 University of Nova Gorica (SI)

PP7 BioNanoNet Forschungs GmbH (AT)

PP8 Association of Chemical & Pharmaceutical Industry of the Slovak Republic (SK)

PP9 Institute of High Pressure Physics, Polish Academy of Sciences (PL)

CEFIC - European Chemical Industry Council

ECRN - European Chemical Regions Network

NANOFORCE project presentation

Associated Institutionssupporting the project

Page 5: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

NANOFORCE specific objectives

Outlining the current situation of the nanotechnology in chemical industry in the Central Europe space

NANOFORCE project presentation

“Nanodeals Generator” Innovative ICT nanotech platform to connect research with the chemical industry (knowledge to business), provide expertise tailored to individual needs & support for innovative SMEs in launching new joint initiatives to boost the Nano R&D and the effectiveness of innovation among chemical nanotech companies in the CE area

Development of the Technology Rating Methodology to provide support and expertise for chemical enterprises in elaborating new initiatives and benchmarking of identified nano-proposals

Capacity building of nanotech SMEs to prepare them to tackle a wider range of innovation challenges in the high-technology areas

Proposal for establishment of the “Interregional Nanotech Venture Capital Fund” to ensure the project follow-up and give a concrete solution of funding to the CE nanotech initiatives

According to EU REACH Reg, deepening research efforts & roadmaps for some key nanotechnology materials which are generally used in the industrial sector of the project regions to assess effects on human health, exposure & environmental impacts and finally demonstrate their proficiency,sustainability and market orientation

Page 6: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

SUPPORTING NANO R&D

COMMERCIALIZATION&

INDUSTRIALIZATION

NANOFORCE Work packages

May 2011 Project duration: 30 months October 2013

Activities

NANOFORCE roadmap and planning

COMMUNICATIONKNOWLEDGE

MANAGEMENT&

DISSEMINATION

WP 1 WP 2 WP 3 WP 4 WP 5 WP 6

EXISTING NANOTECHNOLOGY INFRASTRUCTURES

& STRATEGY TO REDUCE

KNOWLEDGE GAPS

IN CENTRAL EUROPE

“INTERREGIONAL NANOTECH VENTURE

CAPITAL FUND” &

CAPACITY BUILDING

PROJECT MANAGEMENT

&COORDINATION

RESPONSIBLE USE OF

NANOTECH &

ASSOCIATED RISKS

MANAGEMENT

ResponsibleSC - Sviluppo

Chimica LP

ResponsibleSCHP CZ

PP3

ResponsibleVeneto

Nanotech

PP2

ResponsibleBioNanoNet Forschungs

PP7

ResponsibleSC - Sviluppo

ChimicaLP

ResponsiblePIPC PL

PP5

Page 7: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

NANOFORCE target groups

NANOFORCE project presentation

Industrial and Chemical Associations and National

Authorities

European Commission, the European Parliament and the

Economic and Social Committee

Researchers

Venture capitalists

Companies operating in nanotechnology sector

• will benefit of new guidelines to manage nanomaterials and transfer such info to

the SMEs in the regions involved in NANOFORCE

• will be delivered with a White Book of recommendations to advance potential

changes of EU regulation for some specific nanomaterials

• to coordinate nanotech research in CE, more effectively transfer applied research to

industry; support entrepreneurial mindset of researcher to connect R&D to market;

• Banks & venture capitalists will be delivered with all necessary information

to assess positively nano deals for funding

• Large & SMEs need tool to access relevant info on R&D most promising ideas in the field

of nanotechnology to exploit potential markets, create synergies and joint ventures

100

25

100

3

20

Page 8: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

NANOFORCE innovative results

NANOFORCE project presentation

creation of transnational

NANOTECH CLUSTER

& potential venture capitals

“Nanodeals Generator”

Technology

Rating

SYNERGIC SET OF TECHNICAL & FINANCIAL

TOOLSfor chemical enterprises and R&D

centers in a specific macro - regional area to:

address knowledge to business in the nanotech sectors

improve the industrial potential & competitiveness in the nanotech sector in the CE

cooperation space

CE Nanotechnology Roadmap

tailored to be applied to specific market segments that reached sufficient maturity to turn results of

research into industrial processes

Page 9: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Testing

• Specific characterisation and toxicological analysis 3 nanomaterials:

• TiO2, • nanoAG, • ZnO • to be executed in order to validate their registration

process within the context of REACH (Exposure Scenarios/Safety Data Sheets) while assessing their potential health and environmental hazards

Page 10: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Management

Steering Committee – representatives of all partners

WG at each partner level

Page 11: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Working Group Nano at ZCHFP SR

• Establishment of the Working group at the Association level

• Members:– Interested member companies– Slovak University of Technology– Slovak Academy of Science– Ministry of the Environment– Ministry of the Economy

Page 12: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

ZCHFP SR

• Some current results

• Outputs from questionnaires• Survey on related legislation• Survey on possible interested investors• Nano Info Day

Page 13: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Standardised Questionnaire to producers and researchers

• Completed questionnaires: 30

• RandD: 18 (SAS, STU, Institutions)

• RandD + Producers: 5• Producers: 7

Page 14: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

1. General information

Page 15: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Nanotechnology sectors covered by the companies/institutions in Slovakia (overall sample:30)

Workplace safety ChemicalsBiocides Plant protectionCosmetics FoodMedical EnvironmentTextiles ElectronicsSensing/Analytics Polymers/Comp.RD PigmentsCoatings EnergyOthers

Page 16: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

2. Information on nanomaterials / nanoproducts

Page 17: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Generic group of nanomaterials

MetalMetal oxideMetal carbideMetal nitrideMetal sulfideNatural materialsCarbonOrganicBiologicalOthers

Page 18: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Morphology of nanoparticles

Particles

Tubes

Rods

Fibers

Clays

Films

Porous materials

Composites

Solid materials with grain boundaries

Others

Page 19: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Type of formulation used for nanomaterials

Powder

Slurry

Composite

Others

Page 20: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Known/expected specific applications of nanomaterials/nanoproducts

ChemicalsBiocidesPlant protectionCosmeticsFoodMedicalEnvironmentTextilesElectronicsSensing/AnalyticsPolymers/CompositesRDPigmentsCoatingsEnergyOthers

Page 21: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

3. Occupational, consumer and environmental safety

Page 22: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Nanomaterials as hazardous

• Do you consider nanomaterials as hazardous?

YES: 15 NO: 12

• Have you specific safety program for nano in your company?

YES: 12 NO: 2

• Did you develope Exposure scenarios (REACH)?

YES: 4

Page 23: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

What kind of tests do you used/use/plan to use?

• In vitro animal study 4• In vitro human study 3• Specific in vitro study: 2• In vivo 5• Ex vivo 3• Micro- to macro- consm• Field experiments 9

Page 24: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

4. Financial Framework

Page 25: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Used/prefered financial sources

FUNDS USED PREFERED

• Public funds 20 12• Private Funds 6 3• Venture capitals 0 0• EU Funds 12 19

Page 26: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Participation in EU / Int. projects

• FP7 7• Structural funds 10• Others 2

Page 27: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Which role of expertise do you cover within participated projects

• Exposure case study 1• Nanomaterials provider 10• Safety and risk assessment 3• Communication 1• Technology transfer 10

Page 28: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Expected problems with

• Consumer acceptance 4• Politic decisions 4• Current regulation 2

Page 29: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Communication

Page 30: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 31: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 32: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 33: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 34: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 35: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.
Page 36: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

www.nanoforceproject.eu

Page 37: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

www.zchfp.sk

www.rcsk.sk

Page 38: NANOFORCE Association of the Chemical and Pharmaceutical Industry of the Slovak Republic Silvia Surova 25.9.2012 Social Dialogue Brussels.

Thank you very much

for your attention